Sandoz to acquire Just–Evotec Biologics facility for $300 million
The companies will now begin detailed contract negotiations and proceed with necessary consultations and approval processes
The companies will now begin detailed contract negotiations and proceed with necessary consultations and approval processes
Mehta brings strong leadership experience in biopharmaceuticals, life science research, and diagnostics
Our specialty chemical businesses have continued to perform strongly, growing double digit YoY
Trixeo is the first pMDI medicine in AstraZeneca’s portfolio to use the near-zero GWP propellant
NewCo’s pipeline includes five investigational medicines
Novo Nordisk will merge its Research & Early Development and Development functions into a single R&D unit
Aman holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University, New York
Kushwaha previously served as Chief Digital & Information Officer at Jubilant Ingrevia Limited
GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology
Subscribe To Our Newsletter & Stay Updated